Showing posts with label nitrofurantoin. Show all posts
Showing posts with label nitrofurantoin. Show all posts

Sunday, January 28, 2018

UTI in pregnancy: nitrofurantoin and trimethoprim-sulfamethoxazole overprescribed despite potential risks.


Nitrofurantoin and trimethoprim-sulfamethoxazole were commonly prescribed for pregnant women during first trimester in 2014, despite the potential risk associated with these antibiotics, reports the results of analysis of large insurance database by Center for Disease Control(CDC). These findings were reported in the Morbidity and Mortality Weekly Report(MMWR) by CDC issued January 12, 2018.

Pregnant women are routinely screened for UTI in pregnancy and receive antibiotics if they screen positive, because of foreseen serious complication later in pregnancy like pyelonephritis, preterm labor, low birth weight, and sepsis.

ACOG recommends to being selective in prescribing antibiotics during first trimester because of potential of birth defects with certain antibiotics. ACOG recommends that nitrofurantoin and trimethoprim-sulfamethoxazole should only be prescribed in early pregnancy when other antibiotics are found ineffective.

CDC gathered data of about 482,917 pregnancies from Truven Health MarketScan Commercial Database and analyzed it for prescription filled for antibiotics during the first trimester.

All pregnant women between aged 15–44 years with a diagnosis of a UTI from 90 days before LMP through the end of pregnancy were identified to be included in the study. UTI was defined according to the International Classification of Diseases Ninth Revision, Clinical Modification (ICD-9 CM) diagnosis code or presence of cystitis with an outpatient prescription filled.

Women with recurrent UTI or those who were admitted were excluded from study.

The data showed that 34,864 (7.2%) pregnant women had an initial outpatient UTI claim 90 days before or during pregnancy.  UTI was most common during the first trimester (40%) and least common in the third trimester of pregnancy.

Types of antibiotics prescribed differed according to pregnancy status of women, with fluoroquinolones and sulfonamides more commonly prescribed to women within 90 days before their LMP while nitrofurantoin, cephalosporins and penicillins were the drugs of choice during pregnancy.

The most common antibiotics prescribed during the first trimester were nitrofurantoin (34.7%), ciprofloxacin (10.5%), cephalexin (10.3%), and trimethoprim-sulfamethoxazole (7.6%).

This report has its own limitations because UTI was identified only based on codes and not lab reports, some women may have other concomitant infections for which these antibiotics were prescribed, the MarketScan sample was a convenient sample hence could not be generalized to whole of US populations and out of pocket payee women were not included in the study.

Inspite of these limitations,  the report shows that it is important for all healthcare providers to be aware of antibiotic recommendations in pregnancy and be aware that they are prescribing for two in women who are pregnant or who might get pregnant in coming months.   





Tuesday, May 2, 2017

Avoid, if possible or use appropriately: Antibiotics in early pregnancy increases risk of spontaneous miscarriage.

courtesy: fortworthent.net
Use of certain antibiotics in early pregnancy increases the risk of miscarriage, says the results of new nested case control study published in current issue of Canadian Medical Association Journal on May 1, 2017.

Macrolides (excluding erythromycin), quinolones, tetracyclines, sulfonamides and metronidazole consumption increases the odds of spontaneous abortion during early pregnancy as compared to cephalosporin, penicillin or no antibiotics at all.

 Antibiotics are widely prescribed throughout pregnancy and existing literature provides conflicting views on their use.

Flory T. Muanda, M.D and her colleagues analyzed data from Quebec Pregnancy Cohort (1998–2009) and identified 182 369 pregnancies that met the inclusion criteria.

The women were between 15–45 years of age and was continuously covered by insurance for at least a year before the pregnancy. Out of these cohort of women, 8702(4.7%) suffered spontaneous pregnancy loss before 20 weeks of gestation and were considered as cases.

For every case ending in abortion, the researchers identified 10 control patients who matched the case by age, year of pregnancy and gestational dating.

Antibiotic exposure was identified by information obtained from Quebec Public Prescription Drug Insurance Plan. All women who filled atleast one prescription for any type of antibiotic between the first day of gestation and the abortion date or just before pregnancy but it’s use extended around the conception period were considered as exposed.

To study the baseline risk of abortion among the general population, a category was formed of patients who were pregnant with no antibiotic exposure.

About 12,446 (13%) patients consumed antibiotics during pregnancy, of which 1428 ended in spontaneous abortion (16.4% of all pregnancies ending in spontaneous abortion).
The mean gestational age at abortion was 14.1week.

Among the control group, 11,018 (12.6%) of patients were exposed to antibiotics.
Those women who had abortion were a year older than the control group, more likely to visited hospital ER and reported consuming more medicines in general.

Interpretation:
  • After accounting for the confounders, it was seen that nitrofurantoin, erythromycin, penicillins, or cephalosporins were the safest to prescribe with no increased risk of abortion.
  • Use of macrolides (excluding erythromycin), quinolones, tetracyclines, sulfonamides and metronidazole during early pregnancy was associated with an increased risk of spontaneous abortion.
  • The odds of suffering spontaneous abortion were greatest with Norfloxacin (odds ratio 4.81) and Levofloxacin (odds ratio 3.28) as compared to no antibiotic.
  • Safety of Nitrofurantoin supports its use as an alternative to trimethoprim–sulfamethoxazole for the treatment of urinary tract infection during pregnancy.
  • The study findings supported the current guidelines of not using tetracyclines and quinolone class of drugs in pregnancy.
  • Metronidazole exposure was also associated with 70% increased risk of spontaneous abortion, which is similar to a previous Medicaid cohort study that showed a 67% increased risk of spontaneous abortion.
The study has a very large sample size and documented information about exposure and the outcome, eliminating recall bias. The study design also minimized selection bias.

Severity of infection, tobacco/ alcohol use, folic acid intake may serve as confounders and may account for some of the findings, but the researchers took measures like using 2 active comparator groups to address these confounders.


The article full text can be accessed here.